HLA class I-restricted and tumor-specific cytotoxic T lymphocytes from metastatic lymph nodes of esophageal cancers

被引:11
|
作者
Toh, U
Yamana, H
Nakao, M
Imai, Y
Seki, N
Takasu, H
Kaneshige, T
Fujita, H
Shirouzu, K
Itoh, K
机构
[1] KURUME UNIV,SCH MED,DEPT IMMUNOL,KURUME,FUKUOKA 830,JAPAN
[2] KURUME UNIV,SCH MED,DEPT SURG 1,KURUME,FUKUOKA 830,JAPAN
[3] SHIONOGI BIOMED LABS,SETTSU,OSAKA 565,JAPAN
关键词
D O I
10.1006/cimm.1997.1105
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This paper investigates the presence of HLA class I-restricted and tumor-specific cytotoxic T lymphocytes (CTL) in tumor sites of esophageal cancers. Five CTL lines were established from the metastatic lymph nodes or pleural effusion by incubation with interleukin-2 of tumor-infiltrating lymphocytes: cases 1 and 5, HLA-A26- and HLA-A33-restricted and squamous cell carcinoma (SCC)-specific CTL; case 2, HLA-Cw0102-restricted and esophageal SCC-specific CTL; case 3, HLA-A24- and HLA-A26-restricted CTL recognizing histologically different tumor cells; and case 4, HLA-A26-restricted and esophageal SCC-specific CTL. These results suggest the existence of HLA class I-restricted and tumor-specific CTL in metastatic esophageal SCC. (C) 1997 Academic Press.
引用
收藏
页码:137 / 143
页数:7
相关论文
共 50 条
  • [21] Isolation of broadly reactive, tumor-specific, HLA class-I restricted CTL from blood lymphocytes of a breast cancer patient
    Verdegaal, EME
    Huinink, DT
    Hoogstraten, C
    Marijnissen, AK
    Gorsira, MB
    Claas, FHJ
    Osanto, S
    HUMAN IMMUNOLOGY, 1999, 60 (12) : 1195 - 1206
  • [22] Tumor-specific autologous cytotoxic T lymphocytes from tissue sections
    Liu, SQ
    Shiraiwa, H
    Kawai, K
    Hayashi, H
    Akaza, H
    Kim, BS
    Oki, A
    Nishida, M
    Kubo, T
    Hashizaki, K
    Saijo, K
    Ohno, T
    NATURE MEDICINE, 1996, 2 (12) : 1283 - 1283
  • [23] In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8+ cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer
    Santin, AD
    Hermonat, PL
    Ravaggi, A
    Bellone, S
    Pecorelli, S
    Cannon, MJ
    Parham, GP
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (03) : 601 - 609
  • [24] Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes
    Romero, P
    Dunbar, PR
    Valmori, D
    Pittet, M
    Ogg, GS
    Rimoldi, D
    Chen, JL
    Liénard, D
    Cerottini, JC
    Cerundolo, V
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09): : 1641 - 1650
  • [25] HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein
    Brandenburg, AH
    de Waal, L
    Timmerman, HH
    Hoogerhout, P
    de Swart, RL
    Osterhaus, ADME
    JOURNAL OF VIROLOGY, 2000, 74 (21) : 10240 - 10244
  • [26] Isolation of human lymphocyte antigens class I-restricted cytotoxic T lymphocytes against autologous myeloma cells
    Pellat-Deceunynck, C
    Jego, G
    Harousseau, JL
    Vié, H
    Bataille, R
    CLINICAL CANCER RESEARCH, 1999, 5 (03) : 705 - 709
  • [27] Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes
    Kikuchi, M
    Nakao, M
    Inoue, Y
    Matsunaga, K
    Shichijo, S
    Yamana, H
    Itoh, K
    INTERNATIONAL JOURNAL OF CANCER, 1999, 81 (03) : 459 - 466
  • [28] INTELLIGENT MATRICES FOR TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
    LIU, SQ
    SAIJO, K
    KODAMA, M
    OHNO, T
    MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC MATERIALS SENSORS AND SYSTEMS, 1994, 2 (1-2): : 61 - 65
  • [29] Circulating HLA class I-restricted T cells specific for epitopes included in a candidate therapeutic vaccine
    Van der Aa, Annegret
    Desmaretz, Christel
    De Pauw, Sarah
    McKinney, Denise
    Newman, Mark
    Maertens, Geert
    Buyse, Marie-Ange
    HEPATOLOGY, 2006, 44 (04) : 533A - 534A
  • [30] Class I-restricted cytotoxic T cell recognition of split peptide ligands
    Gillanders, WE
    Hanson, HL
    Rubocki, RJ
    Hansen, TH
    Connolly, JM
    INTERNATIONAL IMMUNOLOGY, 1997, 9 (01) : 81 - 89